Login
$AGIO
$29.55 -$0.60 (1.99%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Brian Goff Also a director
Chief Executive Officer
57 Not stated Not stated $5,370,389
Cecilia Jones
Chief Financial Officer
51 Since 2022
4 years
Not stated $2,518,222
James Burns
Chief Legal Officer
48 Since 2022
4 years
2016 $2,369,416
Tsveta Milanova
Chief Commercial Officer
49 Since 2023
3 years
Not stated Not reported
Sarah Gheuens
Chief Medical Officer, Head of Research & Development
47 Not stated 2019 $2,086,680
Krishnan Viswanadhan
Chief Strategy and Operations
Title from the Form 4 dated Jun 18, 2026
47 Not stated Not stated $2,805,026

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Average tenure
6.0 years
from year joined
CEO also chairs the board
No
Jacqualyn A. Fouse
Director Age On board Committees Other public boards 2025 pay Source
Jacqualyn A. Fouse
64 2017
9 years
science and technology committee
Incyte Corporation, Madrigal Pharmaceuticals, Inc. Not stated
Brian Goff
57 2022
4 years
None stated Intellia Therapeutics, Inc. Paid as CEO
Rahul Ballal
48 2022
4 years
audit committee science and technology committee
Enliven Therapeutics, Inc. Not stated
Cynthia Smith
57 2022
4 years
compensation & people committee · Chair
Akebia Therapeutics, Inc., Protara Therapeutics, Inc., Spero Therapeutics, Inc., Tvardi Therapeutics, Inc. $467,157
Kaye Foster
66 2014
12 years
compensation & people committee nominating and corporate governance committee · Chair
Prime Medicine, Inc. $498,407
Maykin Ho
73 2015
11 years
audit committee nominating and corporate governance committee
BioMarin Pharmaceutical Inc., Kyntra Bio, Inc., Neumora Therapeutics, Inc. Not stated
Jeffrey Capello
61 2023
3 years
audit committee · Chair
Neogen Corporation $469,657
Catherine Owen Adams
55 2023
3 years
compensation & people committee
None stated $458,407
David Scadden
73 2017
9 years
nominating and corporate governance committee science and technology committee · Chair
Editas Medicine, Inc. $469,657
Jay Backstrom
71 2025
1 year
science and technology committee
None stated $657,149

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support